Remove Competition Remove Government Remove Leads Remove Prescription
article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. DTC ads do NOT lead to unnecessary Rxs. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. 2wo: DTC marketing is one of the reasons prescription drugs cost so much.

Marketing 285
article thumbnail

Breaking through the forecasting fog – 3 trends that will impact critical medicine supply in 2023

pharmaphorum

Demand has also increased due to changes in prescribing protocols, leading to a higher underlying number of prescriptions for certain antibiotic medicines. Governments will act, but will it be enough? In any case, there is only so much that companies can do on their own – which brings us to the third likely trend for 2023.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Two Key Questions About Payer Strategies in 2023

PM360

What other policy issues or potential changes by the government should companies be aware of? However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position.

article thumbnail

Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug

pharmaphorum

Fast forward to February of this year, and the US Court of Appeals declined Teva’s request to reopen the dispute, on the grounds that it creates uncertainty for generic drugmakers and could lead to a flood of lawsuits against generics with skinny labels that have been on the market for years without challenge.

article thumbnail

What health plans should know about healthcare price transparency

Clarify Health

According to the federal government, out-of-network surprise billing occurs 10 million times a year. It requires that health plans publicly disclose pricing for in-network rates, billed charges, prescription drugs, and the allowed amounts for out-of-network providers. The tool must be an internet-based cost estimator.

article thumbnail

Pharma sector reels as UK Government doubles VPAS payback rate on NHS drugs

Pharmaceutical Technology

Full details of the government’s 2023 VPAS payment calculation may be accessed on the UK Department of Health and Social Care (DHSC) page here. Calculations behind the jump in payback rate The government-calculated 2023 clawback level of 26.5% For 2019–23, this was capped at 2% per year.

article thumbnail

Entry-Level Pharma Sales: It's More Than Just a Job Search (Here's Why)

Contrarian Sales Techniques

Compensation and benefits Competitive payout but may be lower than experienced representatives : At entry-level positions, you’re generally offered a base salary, but sales incentives structures may also be implemented, which (unfortunately) can limit earning potential based on performance. This could include therapeutic areas (e.g.,

Sales 52